ExodusPoint Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527K | Buy |
23,756
+1,812
| +8% | +$40.2K | ﹤0.01% | 1074 |
|
|
2025
Q1 | $408K | Buy |
+21,944
| New | +$408K | ﹤0.01% | 1099 |
|
|
2024
Q4 | – | Sell |
-12,284
| Closed | -$412K | – | 1361 |
|
|
2024
Q3 | $412K | Sell |
12,284
-128,215
| -91% | -$4.3M | ﹤0.01% | 1177 |
|
|
2024
Q2 | $3.52M | Buy |
+140,499
| New | +$3.52M | 0.02% | 481 |
|
|
2024
Q1 | – | Sell |
-24,672
| Closed | -$528K | – | 1341 |
|
|
2023
Q4 | $528K | Sell |
24,672
-15,867
| -39% | -$340K | ﹤0.01% | 949 |
|
|
2023
Q3 | $728K | Sell |
40,539
-48,046
| -54% | -$863K | 0.01% | 1050 |
|
|
2023
Q2 | $1.8M | Sell |
88,585
-45,457
| -34% | -$925K | 0.01% | 773 |
|
|
2023
Q1 | $2.92M | Buy |
134,042
+38,784
| +41% | +$844K | 0.02% | 644 |
|
|
2022
Q4 | $2.95M | Buy |
95,258
+59,017
| +163% | +$1.83M | 0.04% | 488 |
|
|
2022
Q3 | $925K | Sell |
36,241
-71,383
| -66% | -$1.82M | 0.01% | 1110 |
|
|
2022
Q2 | $2.19M | Buy |
107,624
+30,178
| +39% | +$613K | 0.03% | 700 |
|
|
2022
Q1 | $1.92M | Buy |
+77,446
| New | +$1.92M | 0.02% | 748 |
|
|
2021
Q4 | – | Sell |
-7,599
| Closed | -$206K | – | 2090 |
|
|
2021
Q3 | $206K | Sell |
7,599
-26,080
| -77% | -$707K | ﹤0.01% | 1719 |
|
|
2021
Q2 | $873K | Buy |
+33,679
| New | +$873K | 0.01% | 1009 |
|
|
2020
Q4 | – | Sell |
-13,949
| Closed | -$206K | – | 1853 |
|
|
2020
Q3 | $206K | Sell |
13,949
-14,951
| -52% | -$221K | ﹤0.01% | 1405 |
|
|
2020
Q2 | $646K | Buy |
+28,900
| New | +$646K | 0.02% | 929 |
|